Yu-feng Yuan-Yufeng
No. 169 Of Donghu Road
Wuhan, 430071, China
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
PDIA6 exacerbates hepatocellular carcinoma via enhancing proteasome-dependent degradation of AKAP12.
PDIA6 exacerbates hepatocellular carcinoma via enhancing proteasome-dependent degradation of AKAP12.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 31, 2026
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosis.
Journal: Nature communications
Published: November 27, 2025
Correction: Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study.
Journal: British journal of cancer
Published: October 21, 2025
Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models.
Journal: Cell reports. Medicine
Published: June 04, 2025
Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial.
Journal: World journal of gastrointestinal surgery
Published: May 27, 2025
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 08, 2025
Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma.
Journal: Cell death & disease
Published: November 16, 2024
WDR4 drives tumour-associated macrophage reprogramming and tumour progression via selective translation and membrane cholesterol efflux.
Journal: Nature cell biology
Published: November 14, 2024
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive study.
Journal: British journal of cancer
Published: November 01, 2024
A tumor-secreted protein utilizes glucagon release to cause host wasting.
Journal: Cell discovery
Published: May 18, 2024
OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 23, 2023
Last Updated: 09/26/2026